MOUs in the Pharmaceuticals Industry

45 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
TNF Pharmaceuticals Investor Update Conference Call Transcript – March 6, 2025
MOUs
Akers Biosciences, Inc.
Pharmaceuticals
2025
Extension Agreement to Memorandum of Understanding between Vireo Growth Inc. and Bill’s Nursery, Inc. (January 23, 2025)
MOUs
Vireo Health International, Inc.
Pharmaceuticals
2025
Memorandum of Understanding Between Vireo Growth Inc. and Bill’s Nursery, Inc. Regarding Proposed Acquisition
MOUs
Vireo Health International, Inc.
Pharmaceuticals
2024
2024 Memorandum of Understanding between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
MOUs
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2024
Addendum to Memorandum of Agreement Between Drug Enforcement Administration and Bright Green Corporation Regarding Mother Plants and Progenies
MOUs
Bright Green Corp
Pharmaceuticals
2023
Memorandum of Agreement Between DEA and Bright Green Corporation for Bulk Manufacture of Schedule I Controlled Substances
MOUs
Bright Green Corp
Pharmaceuticals
2023
CLS Holdings USA, Inc. Forward-Looking Statements and Business Update Press Release
MOUs
CLS Holdings USA, Inc.
Pharmaceuticals
2023
Binding Letter of Intent for Management Services Agreement between Green Door Redding, LLC and Unrivaled Brands, Inc.
MOUs
Terra Tech Corp.
Pharmaceuticals
2023
Binding Letter of Intent for Management Services Agreement between 510 Retail & Events, Inc. and Unrivaled Brands, Inc.
MOUs
Terra Tech Corp.
Pharmaceuticals
2023
Memorandum of Understanding and Agreement for Technical Services and Short-Term Funding between MJ Holdings, Inc. and Red Earth, LLC
MOUs
MJ Holdings, Inc.
Pharmaceuticals
2022
Memorandum of Agreement Between DEA and Bright Green Corporation for Bulk Manufacture of Schedule I Marihuana for Research
MOUs
Bright Green Corp
Pharmaceuticals
2022
Memorandum of Agreement Between DEA and Bright Green Corporation for Bulk Manufacture of Schedule I Marihuana for Research
MOUs
Bright Green Corp
Pharmaceuticals
2022
Memorandum of Understanding between Yissum Research Development Company and Scopus BioPharma Israel Ltd. for Cannabinoid Molecule Synthesis Study
MOUs
Scopus BioPharma Inc.
Pharmaceuticals
2019
Memorandum of Understanding Between Yissum Research Development Company and Scopus BioPharma Israel Ltd. for Feasibility Study and Potential Licensing
MOUs
Scopus BioPharma Inc.
Pharmaceuticals
2019
Memorandum of Understanding between Yissum Research Development Company and Scopus BioPharma Israel Ltd. for Cannabinoid Molecule Synthesis Study
MOUs
Scopus BioPharma Inc.
Pharmaceuticals
2019
Memorandum of Understanding between Yissum Research Development Company and Scopus BioPharma Israel Ltd. for Feasibility Study Funding and Licensing Rights
MOUs
Scopus BioPharma Inc.
Pharmaceuticals
2019
Memorandum of Understanding Between Canbiola, Inc. and TZ Wholesale LLC for Distribution of CBD Products
MOUs
Canbiola, Inc.
Pharmaceuticals
2019
Memorandum of Understanding Between MJ Holdings, Inc. and Andy Zhang Regarding Medical Marijuana License Applications and Equity Participation
MOUs
MJ Holdings, Inc.
Pharmaceuticals
2018
Binding Memorandum of Understanding Between UNV Medicine Ltd. and Canna Powder Ltd. (October 8, 2018)
MOUs
CANNAPOWDER, INC.
Pharmaceuticals
2018
Memorandum of Understanding Among Amneal Pharmaceuticals LLC, Impax Laboratories, Inc., Amneal Holdings, LLC, Atlas Holdings, Inc., and Paul M. Bisaro Regarding Executive...
MOUs
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Eton Pharmaceuticals September 2017 Shareholder Letter
MOUs
HARROW HEALTH, INC.
Pharmaceuticals
2017
Lexaria Corp. Stakeholder Update Letter Regarding Strategic Shift and Joint Venture Activities
MOUs
Lexaria Bioscience Corp.
Pharmaceuticals
2015
Letter of Intent for Lease and Equity Financing between Lexaria Corp. and Arnprior Bay Property Limited
MOUs
Lexaria Bioscience Corp.
Pharmaceuticals
2014
Clarification Letter Agreement between Targeted Medical Pharma, Inc. and AFH Holding and Advisory, LLC (July 25, 2012)
MOUs
Targeted Medical Pharma, Inc.
Pharmaceuticals
2012
Memorandum of Understanding Between The Regents of the University of Michigan and OncoMed Pharmaceuticals, Inc. Regarding Patent Rights
MOUs
OncoMed Pharmaceuticals Inc
Pharmaceuticals
2012
Memorandum of Understanding Between Alternative Fuels Americas (AFA) and United Biofuels of America (UBA) for Acquisition and Business Combination
MOUs
Kaya Holdings, Inc.
Pharmaceuticals
2011
Memorandum of Understanding for Strategic Partnership between Alternative Fuels Americas, Inc. and Bioenergy Solutions of Central America/Isaac Baldizon
MOUs
Kaya Holdings, Inc.
Pharmaceuticals
2011
Memorandum of Understanding Between Novo Energies Corporation and Immunovative Clinical Research, Inc. Regarding Proposed Merger
MOUs
TAURIGA SCIENCES, INC.
Pharmaceuticals
NY
2011
Lexaria Corp. News Release on Belmont Lake Oil Field Operations and Appointment of Senior VP
MOUs
Lexaria Bioscience Corp.
Pharmaceuticals
2010
Memorandum of Understanding Among Planet Resources Corp. (to be Bakhu Holdings Corp.), Shenzhen Xinhonglian Solar Energy Co., Ltd., BlackEdge Strategic Capital Ltd., and Related...
MOUs
Bakhu Holdings, Corp.
Pharmaceuticals
2009
Memorandum of Understanding Between Bakhu Holding Corp. and Shenzhen Xinhonglian Solar Energy Co., Ltd. for Acquisition
MOUs
Bakhu Holdings, Corp.
Pharmaceuticals
2009
Letter of Intent Between Signature Exploration & Production Corp. and Harry Dawson Regarding Medicine River Ranch Oil and Gas Development
MOUs
GB SCIENCES INC
Pharmaceuticals
2009
Letter of Intent Between Signature Exploration & Production Corp. and Phoenix Energy Regarding Oil & Gas Lease Investment
MOUs
GB SCIENCES INC
Pharmaceuticals
FL
2009
Memorandum of Understanding for Settlement of Indevus Pharmaceuticals Merger Litigation
MOUs
Endo Pharmaceuticals Solutions Inc.
Pharmaceuticals
2009
Exclusive Memorandum of Understanding between Serum Institute of India Ltd. and Akorn Inc. for U.S. Vaccine Development and Marketing
MOUs
Akorn
Pharmaceuticals
2007
Ceragenix Pharmaceuticals Press Release on CSA-13 Antibiotic Study Results and Development Plans
MOUs
CERAGENIX PHARMACEUTICALS, INC.
Pharmaceuticals
2005
Letter Agreement Between Ceragenix Pharmaceuticals, Inc. and Centers for Disease Control Regarding Evaluation of Ceracide™ Coating
MOUs
CERAGENIX PHARMACEUTICALS, INC.
Pharmaceuticals
2005
Memorandum of Understanding and User Agreement Between Advanced Photon Source (Argonne National Laboratory) and Structural GenomiX Collaborative Access Team for Beamline...
MOUs
SGX PHARMACEUTICALS, INC.
Pharmaceuticals
2005
Memorandum of Understanding for Joint Venture Between Terra Tech Corp and Family Hydroponics
MOUs
Terra Tech Corp.
Pharmaceuticals
2012
Memorandum of Understanding for Joint Venture between Terra Tech Corp and The Edible Farm Project
MOUs
Terra Tech Corp.
Pharmaceuticals
2012